Results 11 to 20 of about 316,152 (254)

Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays [PDF]

open access: yesHuman Pathology, 2010
Angiogenesis is required for progression and metastasis of melanoma. Analysis of angiogenic molecules in benign and malignant tissues may allow identification of markers useful for prediction of sensitivity to antiangiogenic agents. We hypothesized that differential expression of vascular endothelial growth factor (VEGF) and its receptors VEGF-R1, VEGF-
Keith T Flaherty   +2 more
exaly   +3 more sources

Neovascular age-related macular degeneration management – Beyond anti-VEGF [PDF]

open access: yesIndian Journal of Ophthalmology
Intravitreal anti-vascular endothelial growth factor (VEGF) therapy has transformed neovascular age-related macular degeneration (nAMD) into a chronic, treatable condition.
Apoorva Ayachit   +7 more
doaj   +2 more sources

N-VEGF, the autoregulatory arm of VEGF-A [PDF]

open access: yesCells, 2021
Vascular endothelial growth factor A (VEGF-A) is a secreted protein that stimulates angiogenesis in response to hypoxia. Under hypoxic conditions, a non-canonical long isoform called L-VEGF is concomitantly expressed with VEGF-A. Once translated, L-VEGF it is proteolytically cleaved to generate N-VEGF and VEGF-A. Interestingly, while VEGF-A is secreted
Marina Katsman   +4 more
openaire   +3 more sources

The Effect of Eight Weeks Resistance and Endurance training on Some Angiogenesis factors of Hippocampus Tissue in male Wistar rats [PDF]

open access: yesفیزیولوژی ورزش و فعالیت بدنی, 2021
Purpose: One of the cause of adaptations due to exercise training is increased capillary density or angiogenesis. increased blood flow to hippocampus tissue causes improvement of memory, learning and neurogenesis process and prevention from accession ...
Mojtaba Sadegh Ghomi   +2 more
doaj   +1 more source

IGF-I combined with exercise improve diabetes-induced vascular dysfunction in heart of male Wistar rats [PDF]

open access: yesJournal of Cardiovascular and Thoracic Research, 2022
Introduction: This research investigates the impact of insulin-like growth factor-I (IGF -I)and exercise on mediators associated with angiogenesis (VEGF-A, TSP-1, and NF-кβ) and capillarization status of the diabetic rats’ hearts.
Zahra Niknam   +3 more
doaj   +1 more source

Influence of initial platinum-based chemotherapy on levels of He-4 protein and VEGF-A in primary tumors and metastases from ovarian cancer

open access: yesСибирский онкологический журнал, 2022
Introduction. Recently, the he-4 protein has received great attention due to its diagnostic and prognostic abilities in epithelial ovarian cancer.
E. M. Frantsiyants   +6 more
doaj   +1 more source

Study the association of Mycoplasma pneumoniae and (rs35445101) HLA-DRB1gene polymorphism with the immune susceptibility to rheumatoid arthritis

open access: yesMedical Journal of Babylon, 2023
Background: Rheumatoid arthritis (RA) is an inflammatory immune disease that primarily affects the joints and has its root cause in immune system malfunction.
Wael Rasheed Obaead Alfatlawi   +2 more
doaj   +1 more source

EFFECT OF TIDEGLUSIB WITH BONE GRAFTING ON NEW BONE FORMATION

open access: yesCumhuriyet Dental Journal, 2021
Objectives: The goal of this study was to observe the regenerative potential of Tideglusib in combination with autogenous and xenograft mandibular defects in rats.
Ufuk Taşdemir   +3 more
doaj   +1 more source

The Relapse of Epithelial Ovarian Cancer Under 2-Year Post-Treatment Observation Based on VEGF-A and VEGFR-2 Expression

open access: yesIndonesian Journal of Cancer, 2023
Background: Epithelial ovarian cancer is one of the most formidable lethal malignancies, with a 5-year survival rate of approximately 35% for advanced-stage ovarian carcinoma and a 10-year follow-up rate of about 18%.
Bambang Dwipoyono   +2 more
doaj   +1 more source

A Novel Approach for Development of Intraocular Biodegradable Ranibizumab Implant: A Solution for Stability of Protein Activity [PDF]

open access: yesAdvanced Pharmaceutical Bulletin, 2021
Purpose: Ranibizumab is a monoclonal antibody fragment, targeting all isoforms of vascular endothelial growth factor A (VEGF-A), a protein involved in angiogenesis. It is used to treat age-related macular degeneration (AMD), retinal vein occlusion (RVO),
Fatemeh Dadgar Pakdel   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy